We have ample experience with efficiently designed and executed drug development projects in pulmonology and allergology. This includes projects in asthma, COPD, pulmonary fibrosis and allergic rhinitis, but also prophylactic vaccination for common viral respiratory tract infections. Studies at CHDR benefit from proprietary patient databases with well-characterised patients, as well as collaborative partnerships with (university) hospitals in the most densely populated urban areas of the Netherlands.

Contact CHDR